-
PEARQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Pear Therapeutics (PEARQ)
Company Profile
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 48.78 mm | 48.78 mm | 48.78 mm | 48.78 mm | 48.78 mm | 48.78 mm |
Cash burn (monthly) | 3.80 mm | 10.10 mm | 9.72 mm | 10.28 mm | 1.25 mm | 6.16 mm |
Cash used (since last report) | 90.29 mm | 240.21 mm | 231.18 mm | 244.48 mm | 29.71 mm | 146.54 mm |
Cash remaining | -41.51 mm | -191.43 mm | -182.40 mm | -195.70 mm | 19.08 mm | -97.76 mm |
Runway (months of cash) | -10.9 | -19.0 | -18.8 | -19.0 | 15.3 | -15.9 |
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 2 |
Closed positions | 54 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 215.31 mm |
Total shares | 22.69 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
LJ10 | 11.55 mm | $107.45 mm |
Arboretum Ventures IV | 10.86 mm | $100.99 mm |
Advisory Research | 188.97 k | $208.00 k |
Westchester Capital Management | 63.18 k | $69.00 k |
California State Teachers Retirement System | 25.87 k | $6.60 mm |
5AM Ventures IV | 0.00 | $0.00 |
JAZZ Human Performance Opportunity Fund | 0.00 | $0.00 |